2d
GlobalData on MSNThermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unitGlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.
Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...
Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said ...
M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...
Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing ...
Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration ...
Companies confirm deal details. Thermo Fisher Scientific (NYSE:TMO) confirmed that it agreed to purchase Solventum's ...
Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business ...
Thermo Fisher Scientific agreed to acquire Solventum's purification and filtration business for $4.1 billion in cash, confirming a report first made in The Wall Street Journal.
Solventum’s Purification & Filtration business is highly complementary to Thermo Fisher’s bioproduction business. Solventum’s ...
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
Shares in Solventum rallied after Thermo Fisher Scientific said it would buy the healthcare company's purification and filtration business for about $4.1 billion. Solventum was spun off from 3M last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results